A car accident leaves an aging patient with severe muscle injuries that won’t heal. Treatment with muscle stem cells from a donor might restore damaged tissue, but doctors are unable to deliver them effectively. A new method may help change this.
Researchers at the Georgia Institute of Technology engineered a molecular matrix, a hydrogel, to deliver muscle stem cells called muscle satellite cells (MuSCs) directly to injured muscle tissue in patients whose muscles don’t regenerate well. In lab experiments on mice, the hydrogel successfully delivered MuSCs to injured, aged muscle tissue to boost the healing process while protecting the stem cells from harsh immune reactions.
The method was also successful in mice with a muscle tissue deficiency that emulated Duchene muscular dystrophy, and if research progresses, the new hydrogel therapy could one day save the lives of people suffering from the disease.
Inflammatory war zone
Simply injecting additional muscle satellite cells into damaged, inflamed tissue has proven inefficient, in part because the stem cells encounter an immune system on the warpath.
“Any muscle injury is going to attract immune cells. Typically, this would help muscle stem cells repair damage. But in aged or dystrophic muscles, immune cells lead to the release a lot of toxic chemicals like cytokines and free radicals that kill the new stem cells,” said Young Jang, an assistant professor in Georgia Tech’s School of Biological Sciences and one of the study’s principal investigators.
Only between 1 and 20 percent of injected MuSCs make it to damaged tissue, and those that do, arrive there weakened. Also, some tissue damage makes any injection unfeasible, thus the need for new delivery strategies.
“Our new hydrogel protects the stem cells, which multiply and thrive inside the matrix. The gel is applied to injured muscle, and the cells engraft onto the tissues and help them heal,” said Woojin Han, a postdoctoral researcher in Georgia Tech’s School of Mechanical Engineering and the paper’s first author.
Han, Jang and Andres Garcia, the study’s other principal investigator, published their results on August 15, 2018, in the journal Science Advances. The National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health funded the research.
Hydrogel: watery nets
Hydrogels often start out as water-based solutions of molecular components that resemble crosses, and other components that make the ends of the crosses attach to each other. When the components come together, they fuse into molecular nets suspended in water, resulting in a material with the consistency of a gel.
If stem cells or a drug are mixed into the solution, when the net, or matrix, forms, it ensnares the treatment for delivery and protects the payload from death or dissipation in the body. Researchers can easily and reliably synthesize hydrogels and also custom-engineer them by tweaking their components, as the Georgia Tech researchers did in this hydrogel.
“It physically traps the muscle satellite cells in a net, but the cells also grab onto chemical latches we engineered into the net,” Han said.
This hydrogel’s added latches, which bond with proteins protruding from stem cells’ membranes, not only increase the cells’ adhesion to the net but also hinder them from committing suicide. Stem cells tend to kill themselves when they’re detached and free-floating.
The chemical components and the cells are mixed in solution then applied to the injured muscle, where the mixture sets to a matrix-gel patch that glues the stem cells in place. The gel is biocompatible and biodegradable.
“The stem cells keep multiplying and thriving in the gel after it is applied,” Jang said. “Then the hydrogel degrades and leaves behind the cells engrafted onto muscle tissue the way natural stem cells usually would be.”
Stem cell breakdown
In younger, healthier patients, muscle satellite cells are part of the natural healing mechanism.
“Muscle satellite cells are resident stem cells in your skeletal muscles. They live on muscle strands like specks, and they’re key players in making new muscle tissue,” Han said.
“As we age, we lose muscle mass, and the number of satellite cells also decreases. The ones that are left get weaker. It’s a double whammy,” Jang said. “At a very advanced age, a patient stops regenerating muscle altogether.”
“With this system we engineered, we think we can introduce donor cells to enhance the repair mechanism in injured older patients,” Han said. “We also want to get this to work in patients with Duchene muscular dystrophy.”
“Duchene muscular dystrophy is surprisingly frequent,” Jang said. “About 1 in 3,500 boys get it. They eventually get respiratory defects that lead to death, so we hope to be able to use this to rebuild their diaphragm muscles.”
If the method goes to clinical trials, researchers will likely have to work around the potential for donor cell rejection in human patients.
The Latest on: Muscle stem cells
via Google News
The Latest on: Muscle stem cells
- Parent Project Muscular Dystrophy Invests $1 Million in Satellos Bioscience to Support New Regenerative Medicine Technologyon January 19, 2021 at 8:00 am
PRNewswire/ -- Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), ...
- A breakthrough discovery could reverse Motor Neurone Disease damageon January 19, 2021 at 3:15 am
Researchers in Scotland have made a breakthrough discovery which could reverse the damage caused by motor neurone disease (MND).Scientists were able to repair the damage using motor neurons grown from ...
- DiNAQOR Acquires EHT Technologies GmbH to Advance Engineered Heart Tissue R&D Capabilitieson January 19, 2021 at 3:00 am
DiNAQOR, a gene therapy platform company, today announced that it has acquired EHT Technologies GmbH, a Germany-based engineered heart ...
- Scientists Reprogram Fat Cells to Repair Injurieson January 14, 2021 at 8:15 am
"While these findings are very exciting, I will keep a lid on my excitement until we get this through to patients." ...
- Study shows how cardiosphere-derived cells replenish damaged tissues in dilated cardiomyopathyon January 12, 2021 at 10:24 pm
Dilated cardiomyopathy (DCM) is a condition caused by the weakening of the heart muscle, affecting the ventricles (chambers in the heart that push blood around the body as it contracts).
- Hope for children with rare heart condition: Novel stem cell therapy to save the dayon January 12, 2021 at 7:24 am
Dilated cardiomyopathy (DCM) is a condition caused by the weakening of the heart muscle, affecting the ventricles (chambers in the heart that push blood around the body as it contracts). If allowed to ...
- Stem cell treatment helps patients with neuromuscular diseaseon January 11, 2021 at 2:10 am
The treatment involves transplanting the patient's own stem cells. Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disease that leads to muscle atrophy, chronic fatigue and speech ...
- Stem cells: Fountain of youth for old mice?on January 3, 2021 at 4:01 pm
The researchers examined a stem/progenitor cell population derived from the muscle of progeria mice and found that compared to those from normal rodents, the cells were fewer in number ...
- Exosomes secreted by hiPSC-derived cardiac cells improve recovery from myocardial infarction in swineon January 2, 2021 at 4:00 pm
Gao and colleagues compared transplanting a mixture of human induced pluripotent stem cell–derived cardiomyocytes, endothelial cells, and smooth muscle cells to transplant of exosomes produced by ...
- This Startup Grows Real Steak From Beef Cells in a Labon December 31, 2020 at 10:25 pm
The meat industry is facing unprecedented disruption, and not only from the red hot market for fake meat. There’s also the growing trend of also real meat grown in “biofarms,” or ...
via Bing News